Where is Remegen headquartered?

Remegen is located in Yantai, shandong province.

Who invested in Remegen?

Remegen has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Remegen?

Remegen closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

remegen.com

Remegen

Remegen is a biopharmaceutical company that researches and develops biological drugs for the treatment of cancer, autoimmune and eye diseases.

Business Model:

Revenue: $0

Employees: 11-50

Geographic Data

Address: 58 Middle Beijing Road

City: Yantai

State: shandong province

Zip: 261400

Country: CN

Financial Info

Stage:

private equity

Raised Last:

$100M

Raised Total:

$100M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Remegen is a biopharmaceutical company that researches and develops biological drugs for the treatment of cancer, autoimmune and eye diseases.

Contact Phone:

Contact Email:

IPO Details

Remegen went public on 4/1/2022 on the Hong Kong Stock Exchange

Listed Exchange:
Hong Kong Stock Exchange

IPO Date:
4/1/2022

Ticker Symbol:
688331

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised
8/2022	Biocytogen	Post-IPO Equity	0

Startup Demographics

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2019	Private Equity Round	9	-	Shenzhen Capital Group Lapam Capital GF Venture Capital Huatai Health Fund Lucion Mingxin China Growth Fund SDIC Unity Capital SDIC Venture Capital Shenzhen Guozhong Venture Capital Management Shenzhen Capital Group Lapam Capital GF Venture Capital Huatai Health Fund Lucion Mingxin China Growth Fund SDIC Unity Capital SDIC Venture Capital Shenzhen Guozhong Venture Capital Management
11/2020	IPO		$515M
3/2020	Private Equity Round		$0	Lilly Asia Ventures Vivo Capital Lake Bleu Capital China Reform Fund Management Janchor Partners OrbiMed Hudson Bay Capital Management Loyal Valley Capital Lake Bleu Capital Lilly Asia Ventures Lilly Asia Ventures Vivo Capital Lake Bleu Capital China Reform Fund Management Janchor Partners OrbiMed Hudson Bay Capital Management Loyal Valley Capital Lake Bleu Capital Lilly Asia Ventures
3/2020	Equity	8	$100M	Lilly Asia Ventures Lake Capital Vivo Capital Janchor Industrialist Investing OrbiMed Hudson Bay Capital Lilly Asia Ventures Vivo Capital Lake Bleu Capital China Reform Fund Management Janchor Partners OrbiMed Hudson Bay Capital Management Loyal Valley Capital Lake Bleu Capital Lilly Asia Ventures
12/2019	Private Equity Round	9	-	Shenzhen Capital Group Lapam Capital Shenzhen Capital Group Lapam Capital

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details